:::

詳目顯示

回上一頁
題名:慢性腎臟病與其相關因子之探討--以社區成人健康檢查資料分析
書刊名:臺灣公共衛生雜誌
作者:吳希文史麗珠張睿詒陳為堅楊銘欽
作者(外文):Wu, Hsi-wenSee, Lai-chuChang, Ray-eChen, Wei-jenYang, Ming-chin
出版日期:2009
卷期:28:5
頁次:頁374-384
主題關鍵詞:慢性腎臟病盛行率相關因子成人健檢CKDChronic kidney diseasePrevalenceAssociated factorsAdult health examination
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:31
目標:末期腎臟衰竭病患消耗許多健保資源。幸而因慢性腎臟病引起的不良後果,是可透過早期偵測早期治療來預防或延緩其發生。本研究目的乃透過大規模社區成人健康檢查之資料,探討臺灣民眾慢性腎臟病之相關因子。方法:以2004-2006年參與桃園縣社區成人健檢的29345位民眾為研究對象,對其健康行為、疾病史、身體檢查、血液檢查、尿液檢查等資料,作描述性統計及以卡方檢定、及羅吉斯迴歸進行資料分析。慢性腎臟病的定義則是以腎絲球過濾率<60ml/min/1.73平方公尺作界定。結果:慢性腎臟病盛行率分別為第三期15.2%、第四期0.7%、第五期0.2%。腎絲球過濾率隨年齡增加而下降,慢性腎臟病盛行率隨之上升,且女性盛行率高於男性。與慢性腎臟病相關的因子有高尿酸、肥胖、高血壓、高血糖、高三酸甘油酯、高膽固醇、代謝症候群。結論:參加成人健康檢查的民眾,在其檢查報告應計算腎絲球過濾率、慢性腎臟病的期別。又依慢性腎臟病相關因子的有無來提醒參加民眾罹患慢性腎臟病的風險,以早期發現、早期治療。
Objectives: Treatment of end stage kidney disease is expensive. Moreover, early detection and appropriate case management can prevent or delay the onset of the adverse outcomes of chronic kidney disease (CKD). The purpose of this study was to identify factors associated with CKD that could be used in community screening to detect CKD early. Methods: We analyzed data from the health examination survey of an outreach community of adults. A total of 29,345 Taoyuan county adults participated in this survey during 2004-2006. Data on health behavior, disease history, physical examination, and blood and urine chemistry were analyzed. Descriptive statistics, χ^2 test, and logistic regression were applied. CKD was defined as an estimated glomerular filtration rate (eGFR) of less than 60ml/min/1.73m^2. Results: The prevalence of stages 3-5 CKD was 15.2%, 0.7%, and 0.2%, respectively; eGFR decreased with increased age, and consequently the prevalence of CKD increased; the prevalence of CKD was higher in females than in males. Factors associated with CKD included hyperuricemia, obesity, hypertension, hyperglycemia, hypertriglyceridemia, hypercholesterolemia, and metabolic syndrome. Conclusions: eGFR and CKD stage should be part of the community-based health examination of adults. Those who present with associated factors of CKD should be advised to seek close follow-up and appropriate treatment.
期刊論文
1.Levey, A. S.、Coresh, J.、Balk, E.、Kausz, A. T.、Levin, A.、Steffes, M. W.、Eknoyan, G.(2003)。National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。Annals of Internal Medicine,139(2),137-147。  new window
2.Chobanian, A. V.、Bakris, G. L.、Black, H. R.、Cushman, W. C.、Green, L. A.、Izzo, J. J.、Oparil, S.(2003)。The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure。JAMA,289(19),2560-2572。  new window
3.National Kidney Foundation(2002)。K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。American Journal of Kidney Diseases,39(2),1-266。  new window
4.Hsu, C. C.、Hwang, S. J.、Wen, C. P.、Chang, H. Y.、Chen, T.、Shiu, R. S.、Yang, W. C.(2006)。High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative Survey。American Journal of Kidney Diseases,48(5),727-738。  new window
5.Wen, C. P.、Cheng, T. Y.、Tsai, M. K.、Chang, Y. C.、Chan, H. T.、Tsai, S. P.、Wen, S. F.、Chiang, P. H.、Hsu, C. C.、Sung, P. K.、Hsu, Y. H.(2008)。All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462,293 adults in Taiwan。The Lancet,371(9631),2173-2182。  new window
6.楊芝青(2007)。慢性腎臟病危險因子的探討。北市醫學雜誌,4,880-9。  延伸查詢new window
7.楊芝青、陳維昭、陳再晉(2007)。我國慢性腎臟病防治工作回顧。血液淨化雜誌,12,49-56。  延伸查詢new window
8.Kuo HW、Tsai SS、Tiao MM、Yang CY(2007)。Epidemiological features of CKD in Taiwan。Am J Kidney Dis,49,46-55。  new window
9.Coresh J, Byrd-Holt D, Astor BC, et al.(2005)。Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000。J Am Soc Nephrol,16,180-8。  new window
10.Coresh, J.、Astor, B. C.、Greene, T.、Eknoyan, G.、Levey, A. S.(2003)。Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey。American journal of kidney diseases,41(1),1-12。  new window
11.Brown WW, Peter RM, Ohmit SE, et al.(2003)。Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP)。Am J Kidney Dis,42,22-35。  new window
12.Chadban SJ, Briganti EM, Kerr PG, et al.(2003)。Prevalence of kidney damage in Australian adults: the AusDiab kidney study。J Am Soc Nephrol,14,S131-8。  new window
13.Chen J, Wildman RP, Gu D, et al.(2005)。Prevalence of decreased kidney function in Chinese adults aged 35-74 years。Kidney Int,68,2837-45。  new window
14.Zhang L, Zhang P, Wang F, et al.(2008)。Prevalence and factors associated with CKD: a population study from Beijing。Am J Kidney Dis,51,373-84。  new window
15.Becker MA, Jolly M.(2006)。Hyperuricemia and associated diseases。Rheum Dis Clin North Am,32,275-93。  new window
16.Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR.(2003)。Screening for proteinuria in US adults: a cost-effectiveness analysis。JAMA,290,3101-14。  new window
17.Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y.(2003)。The effects of weight loss on renal function in patients with severe obesity。J Am Soc Nephrol,14,1480-6。  new window
18.de Zeeuw D, Ramjit D, Zhang Z, et al.(2006)。Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL。Kidney Int,69,1675-82。  new window
19.Eriksen BO, Ingebretsen OC.(2006)。The progression of chronic kidney disease : a 10-year population-based study of the effects of gender and age。Kidney Int,69,375-82。  new window
20.Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D.(2004)。Predictors of newonset kidney disease in a community-based population。JAMA,291,844-50。  new window
21.Freedman BI, Volkova NV, Satko SG, et al.(2005)。Population-based screening for family history of endstage renal disease among incident dialysis patients。Am J Nephrol,25,529-35。  new window
22.Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J.(2003)。Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland。J Am Soc Nephrol,14,2934-41。  new window
23.Iseki, K.、Iseki, C.、Ikemiya, Y.、Fukiyama, K.(1996)。Risk of developing end-stage renal disease in a cohort of mass screening。Kidney International,49(3),800-805。  new window
24.Keane WF, Zhang Z, Lyle PA, et al.(2006)。Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study。Clin J Am Soc Nephrol,1,761-7。  new window
25.McClellan WM, Langston RD, Presley R.(2004)。Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease。J Am Soc Nephrol,15,1912-9。  new window
26.Satko SG, Freedman BI.(2004)。The importance of family history on the development of renal disease。Curr Opin Nephrol Hypertens,13,337-41。  new window
27.Schaeffner ES, Kurth T, Curhan GC, et al.(2003)。Cholesterol and the risk of renal dysfunction in apparently healthy men。J Am Soc Nephrol,14,2084-91。  new window
28.Taal MW, Brenner BM.(2006)。Predicting initiation and progression of chronic kidney disease: developing renal risk scores。Kidney Int,70,1694-705。  new window
29.Tarver-Carr ME, Powe NR, Eberhardt MS.(2002)。Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors。J Am Soc Nephrol,13,2363-70。  new window
30.Wrone EM, Carnethon MR, Palaniappan L, Fortmann SP.(2003)。Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey。Am J Kidney Dis,41,580-7。  new window
31.Huang MC, Chen ME, Hung HC, et al.(2008)。Inadequate energy and excess protein intakes may be associated with worsening renal function in chronic kidney disease。J Ren Nutr,18,187-94。  new window
32.Ma YC, Zuo L, Chen JH, et al.(2006)。Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease。J Am Soc Nephrol,17,2937-44。  new window
33.KDOQI(2006)。KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for anemia in chronic kidney disease。Am J Kidney Dis,47,S11-145。  new window
34.Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW.(1972)。Effects of urea loading in patients with far-advanced renal failure。Mayo Clin Proc,47,21-9。  new window
35.Lindeman, R. D.、Tobin, J.、Shock, N. W.(1985)。Longitudinal studies on the rate of decline in renal function with age。J Am Geriatr Soc.,33,278-285。  new window
36.Butler R, Morris AD, Belch JJ, et al.(2000)。Allopurinal normalizes endothelial dysfunction in type 2 diabetics with mild hypertension。Hypertension,35,746-51。  new window
37.Sanchez- Lozada LG, Nakagawa T, Kang DH, et al.(2006)。Hormonal and cytokine effects of uric acid。Curr Opin Nephrol Hypertens,15,30-3。  new window
38.Sanchez- Lozada LG, Tapia E, Santamaria J, et al.(2005)。Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats。Kidney Int,67,237-47。  new window
39.Scheinman JI.(2003)。Sickle cell disease and the kidney。Semin Nephrol,23,66-76。  new window
40.Mohanram A, Zhang Z, Shahinfar S, et al.(2004)。Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy。Kidney Int,66,1131-8。  new window
41.Park SK, Kang SK.(1995)。Renal function and hemodynamic study in obese Zucker rats。Korean J Int Med,10,48-53。  new window
42.Amin R, Turner C, van Aken S, et al.(2005)。The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study。Kidney Int,68,1740-9。  new window
43.Sakharova OV, Taal MW, Brenner BM.(2001)。Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor。Curr Opin Nephrol Hypertens,10,727-38。  new window
會議論文
1.Yang WC, Hwang SC, Ng YY, et al.(2005)。A huge burden of stage III-V chronic kidney disease in Taiwan: a national prevalence estimate from TW3H QC monitoring。Washington, DC。abstr 262。  new window
研究報告
1.楊五常(2007)。研製慢性腎臟病防治手冊計畫。台北。  延伸查詢new window
2.行政院衛生署(2004)。成人健康體位挑戰1824。台北。  延伸查詢new window
3.行政院衛生署國民健康局(2004)。高血壓防治手冊--高血壓偵測、控制與治療流程指引。台北。  延伸查詢new window
4.行政院衛生署國民健康局(2004)。糖尿病防治手冊(糖尿病預防、診斷與控制流程指引)。台北。  延伸查詢new window
5.行政院衛生署國民健康局(2004)。高血脂防治手冊--國人血脂異常診療及預防指引。台北。  延伸查詢new window
圖書
1.行政院衛生署國民健康局(2007)。中老年身心社會生活狀況長期追蹤調查。臺北市:行政院衛生署。  延伸查詢new window
2.Hochberg MC, Smolen JS, Weinblatt ME, Weisman MH.(2003)。Rheumatology。New York, NY。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE